Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Discovery of cell compartment specific protein-protein interactions using affinity purification combined with tandem mass spectrometry.

Lavallée-Adam M, Rousseau J, Domecq C, Bouchard A, Forget D, Faubert D, Blanchette M, Coulombe B.

J Proteome Res. 2013 Jan 4;12(1):272-81. doi: 10.1021/pr300778b. Epub 2012 Dec 4.

PMID:
23157168
[PubMed - indexed for MEDLINE]
2.

Molecular dynamics and mutational analysis of the catalytic and translocation cycle of RNA polymerase.

Kireeva ML, Opron K, Seibold SA, Domecq C, Cukier RI, Coulombe B, Kashlev M, Burton ZF.

BMC Biophys. 2012 Jun 7;5:11. doi: 10.1186/2046-1682-5-11.

PMID:
22676913
[PubMed]
Free PMC Article
3.

Interaction of RNA polymerase II fork loop 2 with downstream non-template DNA regulates transcription elongation.

Kireeva ML, Domecq C, Coulombe B, Burton ZF, Kashlev M.

J Biol Chem. 2011 Sep 2;286(35):30898-910. doi: 10.1074/jbc.M111.260844. Epub 2011 Jul 5.

PMID:
21730074
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Conformational coupling, bridge helix dynamics and active site dehydration in catalysis by RNA polymerase.

Seibold SA, Singh BN, Zhang C, Kireeva M, Domecq C, Bouchard A, Nazione AM, Feig M, Cukier RI, Coulombe B, Kashlev M, Hampsey M, Burton ZF.

Biochim Biophys Acta. 2010 Aug;1799(8):575-87. doi: 10.1016/j.bbagrm.2010.05.002. Epub 2010 May 15.

PMID:
20478425
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Site-directed mutagenesis, purification and assay of Saccharomyces cerevisiae RNA polymerase II.

Domecq C, Kireeva M, Archambault J, Kashlev M, Coulombe B, Burton ZF.

Protein Expr Purif. 2010 Jan;69(1):83-90. doi: 10.1016/j.pep.2009.06.016. Epub 2009 Jun 28.

PMID:
19567268
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Use of site-specific protein-DNA photocrosslinking of purified complexes to analyze the topology of the RNA polymerase II transcription initiation complex.

Forget D, Domecq C, Coulombe B.

Methods Mol Biol. 2009;543:439-51. doi: 10.1007/978-1-60327-015-1_26.

PMID:
19378180
[PubMed - indexed for MEDLINE]
7.

A method for estimating the probability of adverse drug reactions.

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ.

Clin Pharmacol Ther. 1981 Aug;30(2):239-45. No abstract available.

PMID:
7249508
[PubMed - indexed for MEDLINE]
8.

Sex-related variations in the frequency and characteristics of adverse drug reactions.

Domecq C, Naranjo CA, Ruiz I, Busto U.

Int J Clin Pharmacol Ther Toxicol. 1980;18(8):362-6.

PMID:
7409941
[PubMed - indexed for MEDLINE]
9.

Drug monitoring: the University of Chile Clinical Hospital experience.

Busto U, Naranjo CA, Ruiz I, Domecq C.

Am J Hosp Pharm. 1979 May;36(5):596. No abstract available.

PMID:
453207
[PubMed - indexed for MEDLINE]
10.

[Drug surveillance using trained pharmacists (author's transl)].

Busto U, Ruiz I, Naranjo CA, González G, Domecq C, Castillo M.

Rev Med Chil. 1978 Mar;106(3):188-91. Spanish. No abstract available.

PMID:
663457
[PubMed - indexed for MEDLINE]
11.

[A prospective drug surveillance study at the University of Chile Clinical Hospital (author's transl)].

Naranjo CA, Ruiz I, Busto U, Mayorga L, González G, Castillo M, Domecq C.

Rev Med Chil. 1978 Mar;106(3):176-81. Spanish. No abstract available.

PMID:
663455
[PubMed - indexed for MEDLINE]
12.

[Adverse reactions to antimicrobial agents (author's transl)].

Naranjo CA, Granic D, Domecq C.

Rev Med Chil. 1977 Jan;105(1):4-10. Spanish. No abstract available.

PMID:
882751
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk